FB2025_01 , released February 20, 2025
Allele: Dmel\fra6
Open Close
General Information
Symbol
Dmel\fra6
Species
D. melanogaster
Name
FlyBase ID
FBal0245151
Feature type
allele
Associated gene
Associated Insertion(s)
Carried in Construct
Key Links
Allele class
Mutagen
    Nature of the Allele
    Allele class
    Mutagen
    Progenitor genotype
    Cytology
    Description
    Mutations Mapped to the Genome
    Curation Data
    Type
    Location
    Additional Notes
    References
    Variant Molecular Consequences
    Associated Sequence Data
    DNA sequence
    Protein sequence
     
    Expression Data
    Reporter Expression
    Additional Information
    Statement
    Reference
     
    Marker for
    Reflects expression of
    Reporter construct used in assay
    Human Disease Associations
    Disease Ontology (DO) Annotations
    Models Based on Experimental Evidence ( 0 )
    Disease
    Evidence
    References
    Modifiers Based on Experimental Evidence ( 0 )
    Disease
    Interaction
    References
    Comments on Models/Modifiers Based on Experimental Evidence ( 0 )
     
    Disease-implicated variant(s)
     
    Phenotypic Data
    Phenotypic Class
    Phenotype Manifest In
    Detailed Description
    Statement
    Reference

    fra3/fra6 stage 15 embryos exhibit defects in EW midline axon crossing in approximately 20% of segments.

    EW axons in fra3/fra6 hypomorphic mutants fail to cross in ~20% of segments.

    fra4/fra6 mutant embryos have normal commissure formation and a mild EW axon crossing defect.

    External Data
    Interactions
    Show genetic interaction network for Enhancers & Suppressors
    Phenotypic Class
    Enhanced by
    NOT Enhanced by
    Suppressed by
    Statement
    Reference

    fra6/fra3 has abnormal neuroanatomy phenotype, suppressible by Src64B[+]/Src64Bko

    NOT suppressed by
    Phenotype Manifest In
    Enhanced by
    Statement
    Reference

    fra6/fra3 has axon | embryonic stage phenotype, enhanceable by Df(3R)BSC794

    fra6/fra4 has axon | embryonic stage phenotype, enhanceable by Tace19

    fra6/fra4 has commissure | embryonic stage phenotype, enhanceable by Tace19

    fra6/fra3 has larval EW neuron phenotype, enhanceable by Abl1/Abl[+]

    fra6/fra3 has symmetrical commissure phenotype, enhanceable by Abl1/Abl[+]

    fra6/fra3 has larval EW neuron phenotype, enhanceable by Abl2/Abl[+]

    fra6/fra3 has symmetrical commissure phenotype, enhanceable by Abl2/Abl[+]

    fra6/fra3 has larval EW neuron phenotype, enhanceable by Abl4/Abl[+]

    fra6/fra3 has symmetrical commissure phenotype, enhanceable by Abl4/Abl[+]

    fra6/fra4 has larval EW neuron phenotype, enhanceable by comm[+]/commΔe39

    NOT Enhanced by
    Statement
    Reference

    fra6/fra3 has larval EW neuron phenotype, non-enhanceable by unc-5[+]/unc-52

    fra6/fra3 has larval posterior commissure phenotype, non-enhanceable by unc-5[+]/unc-52

    fra6/fra3 has larval longitudinal connective phenotype, non-enhanceable by unc-5[+]/unc-52

    fra6/fra3 has larval EW neuron phenotype, non-enhanceable by drlR343

    fra6/fra3 has larval EW neuron phenotype, non-enhanceable by drl[+]/drlR343

    fra6/fra3 has larval posterior commissure phenotype, non-enhanceable by drl[+]/drlR343

    Suppressed by
    Statement
    Reference

    fra6/fra3 has larval EW neuron phenotype, suppressible by Src64B[+]/Src64Bko

    fra6/fra3 has larval posterior commissure phenotype, suppressible by Src64B[+]/Src64Bko

    NOT suppressed by
    Statement
    Reference

    fra6/fra3 has larval EW neuron phenotype, non-suppressible by unc-5[+]/unc-52

    fra6/fra3 has larval posterior commissure phenotype, non-suppressible by unc-5[+]/unc-52

    fra6/fra3 has larval longitudinal connective phenotype, non-suppressible by unc-5[+]/unc-52

    fra6/fra3 has larval EW neuron phenotype, non-suppressible by drlR343

    fra6/fra3 has larval EW neuron phenotype, non-suppressible by drl[+]/drlR343

    fra6/fra3 has larval posterior commissure phenotype, non-suppressible by drl[+]/drlR343

    Additional Comments
    Genetic Interactions
    Statement
    Reference

    An Abl1/+ heterozygous background enhances the EW axon midline crossing defects seen in fra3/fra6 stage 15 embryos.

    An Abl2/+ heterozygous background enhances the EW axon midline crossing defects seen in fra3/fra6 stage 15 embryos. However, the addition of AblK417N.Scer\UAS or AblK417N.Scer\UAS.T:Avic\GFP (under the control of Scer\GAL4eg-Mz360) to these embryos reduces the percentage of segments affected with EW midline crossing defects.

    An Abl4/+ heterozygous background increases the number of EW axon midline crossing defects seen in fra3/fra6 stage 15 embryos. However, the addition of AblK417N.Scer\UAS or AblK417N.Scer\UAS.T:Avic\GFP (under the control of Scer\GAL4eg-Mz360) to these embryos significantly reduces the percentage of segments affected with EW midline crossing defects.

    A Src64Bko heterozygous background suppresses the EW axon midline crossing defects found in fra3/fra6 hypomorphic mutants.

    Co-expression of Src64BYF.Scer\UAS under the control of Scer\GAL4eg-Mz360 enhances the EW axon midline crossing defects found in fra3/fra6 hypomorphic mutants.

    An unc-52 heterozygous background does not affect the level EW axon midline crossing defects found in fra3/fra6 hypomorphic mutants.

    A drlR343 homo or heterozygous background does not affect the level EW axon midline crossing defects found in fra3/fra6 hypomorphic mutants.

    The commissural defects seen in fra4/fra6 embryos are enhanced in a heterozygous commE39/+ genetic background as shown by missing and thin commissures in many segments, as well as an increased frequency of non-crossing defects in a subset of of commissural neurons.

    Xenogenetic Interactions
    Statement
    Reference
    Complementation and Rescue Data
    Comments
    Images (0)
    Mutant
    Wild-type
    Stocks (0)
    Notes on Origin
    Discoverer
    External Crossreferences and Linkouts ( 0 )
    Synonyms and Secondary IDs (1)
    References (7)